Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | AMGN | GILD | BIIB | CELG |
| Company | Apellis Pharmaceuticals Inc | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 48.84 | 270.63 | 66.58 | 198.97 | 108.01 |
| High | 50.40 | 274.86 | 67.18 | 205.75 | 108.59 |
| Low | 48.62 | 269.64 | 66.36 | 198.97 | 107.27 |
| Last | 49.93 | 273.01 | 67.08 | 201.99 | 108.24 |
| Change | +1.21 | -0.53 | +0.05 | +8.81 | +0.11 |
| % Change | +2.48% | -0.19% | +0.07% | +4.56% | +0.10% |
| Volume | 1,245,700 | 2,467,100 | 8,467,000 | 3,265,600 | 191,230,496 |
| 20-Day Average Volume | 1,204,865 | 2,172,705 | 6,490,535 | 1,263,995 | 16,188,930 |
| Previous Close | 48.72 | 273.54 | 67.03 | 193.18 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 53.38 | 271.55 | 69.07 | 202.16 | 108.17 |
| 20-Day Raw Stochastic | 26.13% | 44.22% | 14.81% | 44.61% | 63.25% |
| 20-Day Relative Strength | 39.06% | 48.18% | 33.12% | 42.70% | 64.69% |
| Weighted Alpha | -7.89 | +11.15 | -20.78 | -34.68 | +46.30 |
| Today's Opinion | 40% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 40% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 24% Buy | 24% Buy | 88% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.96% since 04/17/24 | +3.39% since 04/17/24 | +0.22% since 04/17/24 | +5.12% since 04/17/24 | -1.97% since 11/13/19 |
| Low | 46.40 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 107.27 on 11/20/19 |
| High | 50.40 on 04/24/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 205.75 on 04/24/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -9.86% since 03/22/24 | -1.14% since 03/22/24 | -7.62% since 03/22/24 | -7.39% since 03/22/24 | +5.14% since 10/18/19 |
| Low | 46.40 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 59.91 on 04/01/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 218.26 on 03/25/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -24.94% since 01/24/24 | -10.64% since 01/24/24 | -15.65% since 01/24/24 | -18.28% since 01/24/24 | +13.63% since 08/20/19 |
| Low | 46.40 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 71.90 on 02/26/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 251.99 on 01/31/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +1.98% since 10/24/23 | -1.13% since 10/24/23 | -14.17% since 10/24/23 | -19.88% since 10/24/23 | +14.14% since 05/20/19 |
| Low | 41.19 on 11/06/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 73.80 on 01/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,874,755 | 146,720,288 | 83,457,512 | 28,080,836 | 77,035,920 |
| Shares Outstanding, K | 120,582 | 536,376 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 396,590,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -528,630,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 146,380,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -88,580,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 0.88 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 02/27/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/07/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 9.96 | 13.18 | 10.99 |